[1] PubMed ID: | 30120220 |
Disease Name: | Bone Neoplasms |
Sample: | neoplasm cell lines |
Dysfunction Pattern: | Expression[highly expressed] |
Validated Method: | Western Blot//Wound Healing Assay//qRT-PCR//MTT//Transwell Assay |
Description: | Compared to the human normal bone cell line, we found lncRNA HULC was over-expressed in all 6 bone neoplasm cell lines, and we finally chose HT1080 and Saos-2 cell lines, which possessed the highest lncRNA HULC expression level, for the subsequent studies. |
Causality: | Yes |
Causal Description: | LncRNA HULC can promote the tumorigenesis of bone neoplasms through increasing the proliferation, invasion, and migration abilities and the expression level of EMT-related factors. |
Clinical-realted Application: | We then observed that the expression level of lncRNA HULC was negatively correlated with overall survival rate of bone neoplasm patients, which means that lncRNA HULC has prognostic value in patients with bone neoplasms. |